Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Equity Ratio (2016 - 2025)

Historic Equity Ratio for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to 0.9.

  • United Therapeutics' Equity Ratio rose 466.98% to 0.9 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.9, marking a year-over-year increase of 466.98%. This contributed to the annual value of 0.88 for FY2024, which is 479.23% up from last year.
  • According to the latest figures from Q3 2025, United Therapeutics' Equity Ratio is 0.9, which was up 466.98% from 0.91 recorded in Q2 2025.
  • United Therapeutics' 5-year Equity Ratio high stood at 0.91 for Q2 2025, and its period low was 0.74 during Q1 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.81 (2023), whereas its average is 0.82.
  • Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 136.54% in 2021, then skyrocketed by 704.96% in 2025.
  • Quarter analysis of 5 years shows United Therapeutics' Equity Ratio stood at 0.77 in 2021, then grew by 3.61% to 0.79 in 2022, then increased by 5.23% to 0.84 in 2023, then grew by 4.79% to 0.88 in 2024, then increased by 2.45% to 0.9 in 2025.
  • Its last three reported values are 0.9 in Q3 2025, 0.91 for Q2 2025, and 0.88 during Q1 2025.